What is Orchard's NAICS code?

Orchard's NAICS code is 541613 (Marketing Consulting Services).

Learn more at LeadIQ.com

Insights

Gathering insights about Orchard…

Similar companies to Orchard

Roku Inc.
$1B$10B

Orchard Tech Stack

Orchard uses 8 technology products and services including WordPress, Open Graph, oEmbed, and more. Explore Orchard's tech stack below.

WordPress
Content Management System
Open Graph
Content Management System
oEmbed
Dev Tools
Google Workspace
Email
jQuery
Javascript Libraries
PHP
Programming Languages
Hostinger
Web Hosting
LiteSpeed
Web Servers

Media & News

Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA
Designation granted under Innovative Licensing and Access Pathway which aims to accelerate development of, and access to, transformative new medicines in the United Kingdom Designation granted under Innovative Licensing and Access Pathway which aims to accelerate development of, and access to, transformative new medicines in the United Kingdom
Apr 30, 2026 | www.globenewswire.com
Orchard Therapeutics Celebrates Addition of Metachromatic Leukodystrophy to the U.S. Recommended Uniform Screening Panel
Newborn screening is the only practical means of diagnosing MLD prior to the onset of symptoms, which is key to achieving optimal outcomes for children and their families with this rapidly progressive disease
Dec 16, 2025 | www.globenewswire.com
Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
Completion of enrollment achieved nearly one year ahead of schedule Primary analysis anticipated two years post-treatment TOKYO and LONDON and BOSTON, July 07, 2025 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a Kyowa Kirin company, today announced the last patient has been treated in a registrational trial evaluating the efficacy and safety of OTL-203, an investigational hematopoietic stem cell (HSC) gene therapy, in patients with the Hurler subtype of mucopolysaccharidosis type I (MPS-IH). The trial (NCT06149403), referred to as HURCULES, compares treatment with OTL-203 to standard of care with allogeneic hematopoietic stem cell transplant (allo-HSCT).
Jul 07, 2025 | www.globenewswire.com
Orchard Therapeutics Announces Reimbursement Agreement in Spain
LONDON, MADRID, and BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a Kyowa Kirin company, announced it has recently reached an agreement with the Interministerial Commission for the Pricing of Medicines of the Directorate of Common Portfolio of Services of the Spanish National Health System (SNS) which will result in reimbursed access to Libmeldy® (atidarsagene autotemcel) for all eligible children with pre-symptomatic late infantile (PSLI), pre-symptomatic early juvenile (PSEJ) or early symptomatic early juvenile (ESEJ)—collectively referred to as early-onset—metachromatic leukodystrophy (MLD).
Feb 28, 2025 | www.globenewswire.com
Orchard Therapeutics Appoints Robin Kenselaar to Chief Commercial Officer and Announces Multiple Business Updates Pertaining to its Approved HSC Gene Therapy for MLD
First U.S. patients being treated with Lenmeldy™ (atidarsagene autotemcel) in a commercial setting; other launch efforts progressing well following Food and Drug Administration approval last year
Feb 12, 2025 | www.globenewswire.com
Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety of tissues and organs, including the CNS Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety of tissues and organs, including the CNS
Feb 03, 2025 | www.globenewswire.com
Orchard Therapeutics Announces Multiple Data Presentations and Publications
Ten presentations at ESGCT 2024 detail the therapeutic potential and applicability of the company's platform in rare neurometabolic diseases and beyond
Oct 23, 2024 | www.globenewswire.com

Orchard's Email Address Formats

Orchard uses at least 2 format(s):

Orchard Email Formats	Example	Percentage
First@lightningorchard.com	John@lightningorchard.com	100%
First@orchardcreative.com	John@orchardcreative.com	100%

Frequently Asked Questions

Where is Orchard's headquarters located?

Orchard's main headquarters is located at 20 Jay Street #1100 Brooklyn, New York United States. The company has employees across 1 continents, including North America.

What is Orchard's stock symbol?

Orchard is a publicly traded company; the company's stock symbol is ORTX.

What is Orchard's official website and social media links?

Orchard's official website is orchardcreative.com and has social profiles on LinkedIn.

What is Orchard's SIC code NAICS code?

Orchard's SIC code is 8742 - Management Consulting Services NAICS code is 541613 - Marketing Consulting Services.

How many employees does Orchard have currently?

As of June 2026, Orchard has approximately 36 employees across 1 continents, including North America. Key team members include Chief Creative Officer: D. K.Head Of Strategy: K. M.Head Of Strategy: S. G.. Explore Orchard's employee directory with LeadIQ.

What industry does Orchard belong to?

Orchard operates in the Advertising Services industry.

What technology does Orchard use?

Orchard's tech stack includes WordPressOpen GraphoEmbedGoogle WorkspacejQueryPHPHostingerLiteSpeed.

What is Orchard's email format?

Orchard's email format typically follows the pattern of First@lightningorchard.com. Find more Orchard email formats with LeadIQ.

When was Orchard founded?

Orchard was founded in 2019.

Orchard

Q: What is Orchard's official website and social media links?

Orchard's official website is orchardcreative.com. Orchard has social profiles on LinkedIn.

Q: How many employees does Orchard have currently?

Orchard has approximately 36 employees.

Q: What technology does Orchard use?

Orchard's tech stack includes Hostinger, WordPress, Cloudflare Bot Management, oEmbed, MySQL.

Advertising ServicesNew York, United States11-50 Employees

Orchard is an independent, strategically led creative agency in the Advertising Services industry, based at 20 Jay Street #1100 in Brooklyn, New York. The company employs 11-50 people. Its teams pair a strategist with a creative partner to work together from research and brief development through to production. Clients describe its process as refreshing, reflecting a collaborative approach to advertising. Orchard has earned industry recognition from organizations including Ad Age, Adweek, Campaign, The Drum, and Inc. Best In Business, with awards and shortlists spanning 2020 to 2026, and more information is available at https://orchardcreative.com.

Company Overview

Headquarters: 20 Jay Street #1100 Brooklyn, New York United States
Website: orchardcreative.com
SIC Code: 8742 - Management Consulting Services
Stock Symbol: ORTX
NAICS Code: 541613 - Marketing Consulting Services
Founded: 2019
Employees: 11-50

Media & News

Funding & Financials

$25M$50M
Orchard's revenue is estimated to be in the range of $25M$50M

Funding & Financials

$25M$50M
Orchard's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Orchard

Roku Inc.

Orchard Tech Stack

Media & News

Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA

Orchard Therapeutics Celebrates Addition of Metachromatic Leukodystrophy to the U.S. Recommended Uniform Screening Panel

Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome

Orchard Therapeutics Announces Reimbursement Agreement in Spain

Orchard Therapeutics Appoints Robin Kenselaar to Chief Commercial Officer and Announces Multiple Business Updates Pertaining to its Approved HSC Gene Therapy for MLD

Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™

Orchard Therapeutics Announces Multiple Data Presentations and Publications

Orchard's Email Address Formats

Frequently Asked Questions

Where is Orchard's headquarters located?

What is Orchard's stock symbol?

What is Orchard's official website and social media links?

What is Orchard's SIC code NAICS code?

How many employees does Orchard have currently?

What industry does Orchard belong to?

What technology does Orchard use?

What is Orchard's email format?

When was Orchard founded?

Orchard

Company Overview

Media & News

Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA

Orchard Therapeutics Celebrates Addition of Metachromatic Leukodystrophy to the U.S. Recommended Uniform Screening Panel

Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?